Timely by DrFirst Aims to Lower Barriers to Specialty Meds

Why It Matters

Specialty drug abandonment drives costly delays for manufacturers and jeopardizes patient outcomes; Timely’s platform directly addresses these inefficiencies, promising faster therapy start‑up and lower administrative burden for providers.

Key Takeaways

• 60% prior‑authorization completion for specialty meds
• 56% reduction in pharmacy change requests
• Patient texting achieves 88% engagement rate
• Platform integrates benefits verification and payer criteria
• Aims to cut specialty drug abandonment rates

Pulse Analysis

Specialty medications have long been a bottleneck in the U.S. healthcare system, with more than half of prescriptions never reaching patients. Complex prior‑authorization (PA) requirements, coverage gaps, and restrictive pharmacy networks create a maze that delays treatment and inflates costs. As payers tighten utilization controls, clinicians spend increasing time navigating paperwork rather than delivering care, leading to high abandonment rates that erode revenue for pharmaceutical firms and compromise patient health.

Timely by DrFirst’s new provider solution tackles these pain points by embedding real‑time decision support into existing e‑prescribing platforms. When a clinician selects a specialty drug, the system instantly surfaces benefits verification, preferred pharmacy options, and the most likely PA criteria, prompting targeted questions that can be answered on the spot. The result is a 60% PA completion rate and a 56% drop in pharmacy change requests, according to the company. After the order is placed, patients receive a personalized text linking to financial assistance resources and education, driving an 88% engagement rate that keeps them informed and motivated to start therapy promptly.

The broader implications extend beyond individual practices. Faster PA turnaround and fewer change requests reduce administrative overhead for health systems, improve formulary adherence for insurers, and accelerate revenue capture for drug manufacturers that invest heavily in specialty launches. As the market shifts toward value‑based care, solutions that streamline medication access and improve adherence will become essential components of the digital health ecosystem, positioning Timely as a strategic partner for stakeholders seeking to lower barriers and enhance outcomes in the specialty space.